These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 32903641)

  • 1. Convalescent Plasma: A Potential Life-Saving Therapy for Coronavirus Disease 2019 (COVID-19).
    Alghamdi AN; Abdel-Moneim AS
    Front Public Health; 2020; 8():437. PubMed ID: 32903641
    [No Abstract]   [Full Text] [Related]  

  • 2. Convalescent plasma for COVID-19 considerations.
    Adiwinata Pawitan J
    Transfus Apher Sci; 2021 Feb; 60(1):102927. PubMed ID: 32878733
    [No Abstract]   [Full Text] [Related]  

  • 3. Implications of Coronavirus Disease 2019 (COVID-19) Antibody Dynamics for Immunity and Convalescent Plasma Therapy.
    Casadevall A; Joyner MJ; Pirofski LA
    Clin Infect Dis; 2021 Aug; 73(3):e540-e542. PubMed ID: 32805024
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of convalescent and nonimmune plasma on mortality of patients with COVID-19: a potential role for antithrombin.
    Gazzaruso C; Valenti C; Coppola A; Gallotti P
    Clin Microbiol Infect; 2021 Apr; 27(4):637-638. PubMed ID: 32919071
    [No Abstract]   [Full Text] [Related]  

  • 5. High-Dose Convalescent Plasma for Treatment of Severe COVID-19 (response).
    De Santis GC; Calado RT
    Emerg Infect Dis; 2022 May; 28(5):1083-1084. PubMed ID: 35447061
    [No Abstract]   [Full Text] [Related]  

  • 6. Covid-19 convalescent plasma and SARS-CoV-2 viral variants.
    Joob B; Wiwanitkit V
    Transfus Clin Biol; 2021 Aug; 28(3):306. PubMed ID: 34116915
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of Convalescent Plasma in the Management of COVID-19.
    Dandachi D; Khalaf SA
    Mo Med; 2021; 118(2):118. PubMed ID: 33840851
    [No Abstract]   [Full Text] [Related]  

  • 8. COVID-19 convalescent plasma therapy and immunodeficiency.
    Mungmunpuntipantip R; Wiwanitkit V
    Transfus Clin Biol; 2021 Aug; 28(3):306-307. PubMed ID: 34116917
    [No Abstract]   [Full Text] [Related]  

  • 9. [Convalescent plasma therapy in COVID-19 patients].
    Ascencios L; Casa L
    Medicina (B Aires); 2021; 81(2):306. PubMed ID: 33906156
    [No Abstract]   [Full Text] [Related]  

  • 10. High-titer convalescent plasma therapy for coronavirus disease 2019 and mortality.
    Cruciani M; Bongiovanni G; Franchini M
    Transfusion; 2021 Jun; 61(6):1988-1990. PubMed ID: 33913168
    [No Abstract]   [Full Text] [Related]  

  • 11. [COVID-19: blood sufficiency versus convalescent plasma?].
    Contreras M
    Rev Med Chil; 2020 Jun; 148(6):721-723. PubMed ID: 33480368
    [No Abstract]   [Full Text] [Related]  

  • 12. Controlled trials needed to prove efficacy and safety of convalescent plasma therapy in coronavirus disease 2019.
    Hartog N; Holsworth A; Rajasekaran S
    Ann Allergy Asthma Immunol; 2021 Feb; 126(2):122-123. PubMed ID: 33161152
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19 convalescent plasma therapy: hit fast, hit hard!
    Focosi D; Franchini M
    Vox Sang; 2021 Oct; 116(9):935-942. PubMed ID: 33794556
    [No Abstract]   [Full Text] [Related]  

  • 14. Convalescent plasma therapy in patients with COVID-19.
    Altuntas F; Yigenoglu TN; Bascı S; Dal MS; Korkmaz S; Turgut B; Erkurt MA
    Transfus Apher Sci; 2021 Feb; 60(1):103017. PubMed ID: 33277207
    [No Abstract]   [Full Text] [Related]  

  • 15. How Safe Is COVID-19 Convalescent Plasma?
    Franchini M; Cruciani M
    Mayo Clin Proc; 2021 Aug; 96(8):2279-2281. PubMed ID: 34353475
    [No Abstract]   [Full Text] [Related]  

  • 16. Correspondence on 'CONVALESCENT plasma for COVID-19'.
    Mungmunpuntipantip R; Wiwanitkit V
    Eur J Clin Invest; 2021 Nov; 51(11):e13677. PubMed ID: 34487554
    [No Abstract]   [Full Text] [Related]  

  • 17. COVID-19 convalescent plasma; time for "goal directed therapy"?
    Knudson CM; Jackson JB
    Transfusion; 2021 May; 61(5):1654-1656. PubMed ID: 33723852
    [No Abstract]   [Full Text] [Related]  

  • 18. Convalescent plasma (CP) therapy in patients with COVID-19.
    Cakir B
    Transfus Apher Sci; 2021 Feb; 60(1):103018. PubMed ID: 33257204
    [No Abstract]   [Full Text] [Related]  

  • 19. Convalescent plasma for administration of passive antibodies against viral agents.
    Di Minno G; Mannucci PM; Ironside JW; Perno CF; Gürtler L; Aledort L
    Haematologica; 2020 Dec; 105(12):2710-2715. PubMed ID: 33256373
    [No Abstract]   [Full Text] [Related]  

  • 20. In Reply-How Safe Is COVID-19 Convalescent Plasma?
    Joyner MJ; Klompas AM; Klassen SA; Senefeld JW; Fairweather D; Wright RS; Carter RE
    Mayo Clin Proc; 2021 Aug; 96(8):2281-2282. PubMed ID: 34353476
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.